Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leila E Mansoor

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
The Annals of Pharmacotherapy|July 5, 2003
Effect of pictograms on readability of patient information materialsLeila E Mansoor, Ros Dowse
AIDS Care|November 2, 2016
Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptakeEliza M Govender, Leila E Mansoor, Quarraisha Abdool Karim
AIDS and Behavior|July 1, 2016
Measurement of Vaginal Microbicide Adherence Using Visual Inspection as Compared to Ultra Violet Light Assessment of Returned Empty Gel ApplicatorsMichele Upfold, Anneke Grobler, Fatima Suleman, et al.
Frontiers in Global Women'S Health|January 22, 2025
Disclosure of oral pre-exposure prophylaxis use for HIV prevention among women enrolled in a contraceptive study: qualitative findings from Durban, South AfricaIvana Beesham, Mags Beksinska, Cecilia Milford, et al.
International Journal of Clinical Pharmacy|October 17, 2013
Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infectionTanuja N Gengiah, Atika Moosa, Anushka Naidoo, et al.
Journal of Medical Ethics|March 29, 2017
Undue inducement: a case study in CAPRISA 008Kathryn T Mngadi, Jerome A Singh, Leila E Mansoor, et al.
AIDS and Behavior|February 26, 2013
Adherence support approaches in biomedical HIV prevention trials: experiences, insights and future directions from four multisite prevention trialsK Rivet Amico, Leila E Mansoor, Amy Corneli, et al.
AIDS and Behavior|May 23, 2023
Experience with Contraceptive Dosage Forms and Interest in Novel PrEP Technologies in WomenClaudia J Jansen van Vuuren, Lara Lewis, Ishana Harkoo, et al.
AIDS and Behavior|February 5, 2022
Daily Oral Pre-exposure Prophylaxis (PrEP) Continuation Among Women from Durban, South Africa, Who Initiated PrEP as Standard of Care for HIV Prevention in a Clinical TrialIvana Beesham, Dvora L Joseph Davey, Mags Beksinska, et al.
African Journal of AIDS Research : AJAR|March 23, 2023
Key stakeholders' perspectives on providing oral pre-exposure prophylaxis as HIV-prevention standard of care in clinical trials in South AfricaIvana Beesham, Cecilia Milford, Dvora L Joseph Davey, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
The Annals of Pharmacotherapy|July 5, 2003
Effect of pictograms on readability of patient information materialsLeila E Mansoor, Ros Dowse
AIDS Care|November 2, 2016
Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptakeEliza M Govender, Leila E Mansoor, Quarraisha Abdool Karim
AIDS and Behavior|July 1, 2016
Measurement of Vaginal Microbicide Adherence Using Visual Inspection as Compared to Ultra Violet Light Assessment of Returned Empty Gel ApplicatorsMichele Upfold, Anneke Grobler, Fatima Suleman, et al.
Frontiers in Global Women'S Health|January 22, 2025
Disclosure of oral pre-exposure prophylaxis use for HIV prevention among women enrolled in a contraceptive study: qualitative findings from Durban, South AfricaIvana Beesham, Mags Beksinska, Cecilia Milford, et al.
International Journal of Clinical Pharmacy|October 17, 2013
Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infectionTanuja N Gengiah, Atika Moosa, Anushka Naidoo, et al.
Journal of Medical Ethics|March 29, 2017
Undue inducement: a case study in CAPRISA 008Kathryn T Mngadi, Jerome A Singh, Leila E Mansoor, et al.
AIDS and Behavior|February 26, 2013
Adherence support approaches in biomedical HIV prevention trials: experiences, insights and future directions from four multisite prevention trialsK Rivet Amico, Leila E Mansoor, Amy Corneli, et al.
AIDS and Behavior|May 23, 2023
Experience with Contraceptive Dosage Forms and Interest in Novel PrEP Technologies in WomenClaudia J Jansen van Vuuren, Lara Lewis, Ishana Harkoo, et al.
AIDS and Behavior|February 5, 2022
Daily Oral Pre-exposure Prophylaxis (PrEP) Continuation Among Women from Durban, South Africa, Who Initiated PrEP as Standard of Care for HIV Prevention in a Clinical TrialIvana Beesham, Dvora L Joseph Davey, Mags Beksinska, et al.
African Journal of AIDS Research : AJAR|March 23, 2023
Key stakeholders' perspectives on providing oral pre-exposure prophylaxis as HIV-prevention standard of care in clinical trials in South AfricaIvana Beesham, Cecilia Milford, Dvora L Joseph Davey, et al.
Pageof 7